放射腫瘤學/隨機
外觀
< 放射腫瘤學
|
|
A
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Adolescents, Cancer in
Adrenocortical Carcinoma
AIDS-Related Cancers
Kaposi Sarcoma (Soft Tissue Sarcoma)
AIDS-Related Lymphoma (Lymphoma)
Primary CNS Lymphoma (Lymphoma)
Anal Cancer
Appendix Cancer - see Gastrointestinal Neuroendocrine Tumors
Astrocytomas, Childhood (Brain Cancer)
Atypical Teratoid/Rhabdoid Tumor, Childhood, Central Nervous System (Brain Cancer)
B
Basal Cell Carcinoma of the Skin - see Skin Cancer Bile Duct Cancer Bladder Cancer Bone Cancer (includes Ewing Sarcoma and Osteosarcoma and Malignant Fibrous Histiocytoma) Brain Tumors Breast Cancer Bronchial Tumors (Lung Cancer) Burkitt Lymphoma - see Non-Hodgkin Lymphoma
C
Carcinoma of Unknown Primary
Central Nervous System
Atypical Teratoid/Rhabdoid Tumor, Childhood (Brain Cancer)
Medulloblastoma and Other CNS Embryonal Tumors, Childhood (Brain Cancer)
Germ Cell Tumor, Childhood (Brain Cancer)
Primary CNS Lymphoma
Cervical Cancer
Childhood Cancers
Childhood Cardiac Tumors Treatment
Cancers of Childhood, Rare
Cholangiocarcinoma - see Bile Duct Cancer
Chordoma, Childhood (Bone Cancer)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelogenous Leukemia (CML)
Chronic Myeloproliferative Neoplasms
Colorectal Cancer
Craniopharyngioma, Childhood (Brain Cancer)
Cutaneous T-Cell Lymphoma - see Lymphoma (Mycosis Fungoides and Sézary Syndrome)
D
Ductal Carcinoma In Situ (DCIS) - see Breast Cancer
E
Embryonal Tumors, Medulloblastoma and Other Central Nervous System, Childhood (Brain Cancer)
Endometrial Cancer (Uterine Cancer)
Ependymoma, Childhood (Brain Cancer)
Esophageal Cancer
Esthesioneuroblastoma (Head and Neck Cancer)
Ewing Sarcoma (Bone Cancer)
Extracranial Germ Cell Tumor, Childhood
Extragonadal Germ Cell Tumor
Eye Cancer
Intraocular Melanoma
Retinoblastoma
F
Fallopian Tube Cancer
G
Gallbladder Cancer
Gastric (Stomach) Cancer
Gastrointestinal Neuroendocrine Tumors
Gastrointestinal Stromal Tumors (GIST) (Soft Tissue Sarcoma)
Germ Cell Tumors
Childhood Central Nervous System Germ Cell Tumors (Brain Cancer)
Childhood Extracranial Germ Cell Tumors
Extragonadal Germ Cell Tumors
Ovarian Germ Cell Tumors
Testicular Cancer
Gestational Trophoblastic Disease
H
Hairy Cell Leukemia Head and Neck Cancer Heart Tumors, Childhood Hepatocellular (Liver) Cancer Histiocytosis, Langerhans Cell Hodgkin Lymphoma Hypopharyngeal Cancer (Head and Neck Cancer)
I
Intraocular Melanoma Islet Cell Tumors, Pancreatic Neuroendocrine Tumors
K
Kaposi Sarcoma (Soft Tissue Sarcoma) Kidney (Renal Cell) Cancer
L
Langerhans Cell Histiocytosis Laryngeal Cancer (Head and Neck Cancer) Leukemia Lip and Oral Cavity Cancer (Head and Neck Cancer) Liver Cancer Lung Cancer (Non-Small Cell, Small Cell, Pleuropulmonary Blastoma, Pulmonary Inflammatory Myofibroblastic Tumor, and Tracheobronchial Tumor) Lymphoma
M
Male Breast Cancer Melanoma Melanoma, Intraocular (Eye) Merkel Cell Carcinoma (Skin Cancer) Mesothelioma, Malignant Metastatic Cancer Metastatic Squamous Neck Cancer with Occult Primary (Head and Neck Cancer) Midline Tract Carcinoma With NUT Gene Changes Mouth Cancer (Head and Neck Cancer) Multiple Endocrine Neoplasia Syndromes Multiple Myeloma/Plasma Cell Neoplasms Mycosis Fungoides (Lymphoma) Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms Myelogenous Leukemia, Chronic (CML) Myeloid Leukemia, Acute (AML) Myeloproliferative Neoplasms, Chronic
N
Nasal Cavity and Paranasal Sinus Cancer (Head and Neck Cancer) Nasopharyngeal Cancer (Head and Neck Cancer) Neuroblastoma Neuroendocrine Tumors (Gastrointestinal) Non-Hodgkin Lymphoma Non-Small Cell Lung Cancer
O
Oral Cancer, Lip and Oral Cavity Cancer and Oropharyngeal Cancer (Head and Neck Cancer) Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment Ovarian Cancer
P
Pancreatic Cancer Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Papillomatosis (Childhood Laryngeal) Paraganglioma Paranasal Sinus and Nasal Cavity Cancer (Head and Neck Cancer) Parathyroid Cancer Penile Cancer Pharyngeal Cancer (Head and Neck Cancer) Pheochromocytoma Pituitary Tumor Plasma Cell Neoplasm/Multiple Myeloma Pleuropulmonary Blastoma (Lung Cancer) Pregnancy and Breast Cancer Primary Central Nervous System (CNS) Lymphoma Primary Peritoneal Cancer Prostate Cancer Pulmonary Inflammatory Myofibroblastic Tumor (Lung Cancer)
R
Rare Cancers of Childhood Rectal Cancer Recurrent Cancer Renal Cell (Kidney) Cancer Retinoblastoma Rhabdomyosarcoma, Childhood (Soft Tissue Sarcoma)
S
Salivary Gland Cancer (Head and Neck Cancer)
Sarcoma
Childhood Rhabdomyosarcoma (Soft Tissue Sarcoma)
Childhood Vascular Tumors (Soft Tissue Sarcoma)
Ewing Sarcoma (Bone Cancer)
Kaposi Sarcoma (Soft Tissue Sarcoma)
Osteosarcoma (Bone Cancer)
Soft Tissue Sarcoma
Uterine Sarcoma
Sézary Syndrome (Lymphoma)
Skin Cancer
Small Cell Lung Cancer
Small Intestine Cancer
Soft Tissue Sarcoma
Squamous Cell Carcinoma of the Skin - see Skin Cancer
Squamous Neck Cancer with Occult Primary, Metastatic (Head and Neck Cancer)
Stomach (Gastric) Cancer
T
T-Cell Lymphoma, Cutaneous - see Lymphoma (Mycosis Fungoides and Sèzary Syndrome)
Testicular Cancer
Throat Cancer (Head and Neck Cancer)
Nasopharyngeal Cancer
Oropharyngeal Cancer
Hypopharyngeal Cancer
Thymoma and Thymic Carcinoma
Thyroid Cancer
Tracheobronchial Tumors (Lung Cancer)
Transitional Cell Cancer of the Renal Pelvis and Ureter (Kidney (Renal Cell) Cancer)
U
Unknown Primary, Carcinoma of Ureter and Renal Pelvis, Transitional Cell Cancer (Kidney (Renal Cell) Cancer Urethral Cancer Uterine Cancer, Endometrial Uterine Sarcoma
V
Vaginal Cancer Vascular Tumors (Soft Tissue Sarcoma) Vulvar Cancer
W
Wilms Tumor and Other Childhood Kidney Tumors
Y
Young Adults, Cancer in
(正在交叉連結中)
- 肛管
- 良性疾病
- 膀胱
- 腦轉移
- 乳腺
- 宮頸
- 膽管癌
- 結腸
- 子宮內膜
- 癲癇
- 食管
- 胃
- 神經膠質瘤
- 頭頸部
- 霍奇金淋巴瘤
- 足跟刺
- 卡波西肉瘤
- 肺癌,非小細胞肺癌
- 肺癌,小細胞肺癌
- 淋巴瘤,非霍奇金淋巴瘤
- 髓母細胞瘤
- 間皮瘤
- 黑色素瘤,皮膚
- 黑色素瘤,眼部
- 胰腺
- 前列腺
- 直腸
- 肉瘤
- 皮膚非黑色素瘤
- 脊髓壓迫
- 上腔靜脈綜合徵
- 睪丸,非精原細胞腫瘤
- 胸腺瘤
- 血管腔內放射治療
- 腎母細胞瘤 (威姆斯瘤)
- 熱療
- 支援性護理
- RT 技術
- 質子治療
- 肯塔基州;2009 PMID 19111269 -- "需要對創新放射治療技術進行隨機前瞻性試驗。" (Halperin EC, J Am Coll Radiol. 2009 年 1 月;6(1):33-7.)
- "可以確定應在廣泛臨床實踐中引入之前,需要在隨機前瞻性臨床試驗中證明其效益的創新。"
- 加拿大國家癌症研究所;2008 (1975–2004) PMID 18955452 -- "三十年來腫瘤學隨機對照試驗的演變。" (Booth CM, J Clin Oncol. 2008 年 10 月 27 日。[提前發表])
- 回顧了 321 份評估乳腺癌、CRC 和 NSCLC 系統治療的 RCT 報告。
- 結果:RCT 的數量和規模大幅增加。營利性贊助大幅增加(4% 至 57%,SS)。效應量保持穩定,但作者更有可能強烈支援實驗組(SS)。對實驗組的支援與行業贊助密切相關。
- 威斯康星州;2008 PMID 18237799 -- "健康技術評估中的隨機對照試驗:過度嗎?還是姍姍來遲?" (Bentzen SM, Radiother Oncol. 2008 年 1 月 29 日 [提前發表])
- 牛津大學;2007 PMID 17303884 -- "何時隨機試驗不必要?從噪聲中識別訊號。" (Glasziou P, BMJ. 2007 年 2 月 17 日;334(7589):349-51.)
- RTOG;2005 (1968–2002) PMID 15728168 -- "放射腫瘤學新療法的評價:它們比標準療法好嗎?" (Soares HP, JAMA. 2005 年 2 月 23 日;293(8):970-8.)
- 回顧了所有已完成的 III 期 RTOG 試驗。57 項試驗,12734 名患者
- 結果:干預組相對於標準組的生存 OR 為 1.01 (NS)。只有 10% 顯著優於標準組,88% 結論不確定。
- 毒性:干預組與治療相關的死亡率 OR 為 1.76,高於標準組 (SS)。
- 結論:無法提前預測個別試驗的結果。
- COG;2005 (1955–1997) PMID 16299015 -- "兒童癌症的實驗治療是否優於既定治療?對兒童腫瘤學組隨機對照試驗的觀察性研究。" (Kumar A, BMJ. 2005 年 12 月 3 日;331(7528):1295. 2005 年 11 月 18 日提前發表)
- 回顧了已完成的 III 期試驗。126 項試驗,36567 名患者。
- 結果:生存 OR 為 0.96 (NS)。
- 結論:兒童癌症的新治療方法與既定治療方法相比,同樣有可能效力較低,也有可能效力較高。